On September 28, 2016, in Mylan Pharmaceuticals Inc. v. Warner Chilcott Public Limited Co. (Doryx), the Third Circuit affirmed the lower court's grant of summary judgment against antitrust claims by ...
To prevail in a product-hopping case, a plaintiff must be prepared to establish both monopoly power and anticompetitive effects. On September 28, a unanimous panel of the U.S. Court of Appeals for the ...
Lupin has received the Food and Drug Administration’s green light for Doxycycline Hyclate Delayed-Release tablets, 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 120 mg, 150 mg and 200 mg, which is the generic ...
DUBLIN, Feb. 9, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Mayne Pharma, under which it will divest the U.S. rights to the Doryx® brand ...
Ten years ago, consumers were on the verge of getting a lower-priced, generic version of the brand name antibiotic Doryx (doxycycline). But the drug's manufacturer, Warner Chilcott, stopped making the ...
HAYWARD, Calif.--(BUSINESS WIRE)-- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New ...
Actavis plc (ACT) entered into an agreement with Mayne Pharma for the divestment of U.S. rights to Doryx (acne) and related assets. Actavis will receive $50 million on completion of the deal. The deal ...
Doxycycline (as hyclate) 60mg; del-rel tabs; contains sodium. Swallow whole. Take with fluids; may give with food or milk if gastric irritation occurs. 120mg every 12hrs for 1 day, then 120mg daily ...
June 23 (Reuters) - Warner Chilcott Ltd said it received approval from the U.S. Food and Drug Administration for the 150mg dosage of its Doryx Delayed-Release tablets used for treating severe acne.
Warner Chilcott announced the launch of a 200mg dosage strength for Doryx (doxycycline hyclate) delayed-release tablets. Doryx is a tetracycline antibiotic indicated as adjunct treatment in severe ...
The acquisition of Doryx® (doxycycline hyclate delayed-release tablets), indicated for the adjunctive treatment of severe acne*, spearheads the launch of Mayne Pharma's U.S. Specialty Brands division, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results